Showing results (81-90 of 191) with videos related to

Sort By:
Pageof 20
Cancer Immunology Research|January 11, 2015
Peptide/MHC tetramer-based sorting of CD8⁺ T cells to a leukemia antigen yields clonotypes drawn nonspecifically from an underlying restricted repertoireSally A Hunsucker, Colleen S McGary, Benjamin G Vincent, et al.
Blood|January 14, 2014
Intravital imaging of donor allogeneic effector and regulatory T cells with host dendritic cells during GVHDKaifeng Lisa Lin, LeShara M Fulton, Matthew Berginski, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2004
CD30/CD30 ligand (CD153) interaction regulates CD4+ T cell-mediated graft-versus-host diseaseBruce R Blazar, Robert B Levy, Tak W Mak, et al.
Cancer Research|December 17, 2010
The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cellsHendrik W van Deventer, Joseph E Burgents, Qing Ping Wu, et al.
International Journal of Molecular Sciences|February 5, 2020
Influence of Germline Genetics on Tacrolimus Pharmacokinetics and Pharmacodynamics in Allogeneic Hematopoietic Stem Cell Transplant PatientsJing Zhu, Tejendra Patel, Jordan A Miller, et al.
Blood Advances|September 20, 2018
Impaired bone marrow B-cell development in mice with a bronchiolitis obliterans model of cGVHDOleg V Kolupaev, Trisha A Dant, Hemamalini Bommiasamy, et al.
Translational Oncology|August 31, 2020
Tumor neoantigen heterogeneity impacts bystander immune inhibition of pancreatic cancer growthManisit Das, Xuefei Zhou, Yun Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2004
Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomibKai Sun, Lisbeth A Welniak, Angela Panoskaltsis-Mortari, et al.
Pageof 20